Cargando…
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
BACKGROUND: Over the month of April, Spain has become the European country with more confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of Castile and León in Spain is one of the most affected by COVID-19 infection and the province of León has a total of 3711 c...
Autores principales: | Santos, C. Sieiro, Morales, C. Moriano, Álvarez, E. Díez, Castro, C. Álvarez, Robles, A. López, Sandoval, T. Perez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383119/ https://www.ncbi.nlm.nih.gov/pubmed/32720259 http://dx.doi.org/10.1007/s10067-020-05301-2 |
Ejemplares similares
-
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
por: Santos, Cristiana Sieiro, et al.
Publicado: (2021) -
Clinical phenotype in scleroderma patients based on autoantibodies
por: Santos, Cristiana Sieiro, et al.
Publicado: (2023) -
Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
por: Sieiro Santos, Cristiana, et al.
Publicado: (2022) -
Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2
por: Sieiro Santos, C., et al.
Publicado: (2020) -
Post-coronavirus disease syndrome and disseminated microthrombosis: the role of the von Willebrand factor and antiphospholipid antibodies
por: Sieiro-Santos, Cristiana, et al.
Publicado: (2021)